KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Long-Term Deferred Tax: 2019-2024

Historic Long-Term Deferred Tax for Xenon Pharmaceuticals (XENE) over the last 6 years, with Dec 2024 value amounting to $9.7 million.

  • Xenon Pharmaceuticals' Long-Term Deferred Tax rose 1014.80% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 1014.80%. This contributed to the annual value of $9.7 million for FY2024, which is 1105.24% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Long-Term Deferred Tax of $9.7 million as of FY2024, which was up 1,105.24% from $802,000 recorded in FY2023.
  • In the past 5 years, Xenon Pharmaceuticals' Long-Term Deferred Tax registered a high of $9.7 million during FY2024, and its lowest value of $465,000 during FY2021.
  • For the 3-year period, Xenon Pharmaceuticals' Long-Term Deferred Tax averaged around $3.7 million, with its median value being $802,000 (2023).
  • Per our database at Business Quant, Xenon Pharmaceuticals' Long-Term Deferred Tax dropped by 11.09% in 2021 and then skyrocketed by 1,105.24% in 2024.
  • Over the past 5 years, Xenon Pharmaceuticals' Long-Term Deferred Tax (Yearly) stood at $523,000 in 2020, then decreased by 11.09% to $465,000 in 2021, then climbed by 9.46% to $509,000 in 2022, then spiked by 57.56% to $802,000 in 2023, then skyrocketed by 1,105.24% to $9.7 million in 2024.